CFRI Community, CFRI’s newsletter, is printed and distributed twice annually, in the spring and fall of each year. Containing articles on topics of interest to the cystic fibrosis (CF) community, updates on CF research, and announcements of CFRI’s programs, events and services, CFRI Community is mailed to 15,000 subscribers around the globe. An additional 17,000 digital subscribers receive notices when the latest issue has been released.
Issues of CFRI Community, along with the Spanish-language version, CFRI Communidad, are archived and can be accessed through the link below.
CFRI Community is sponsored by Vertex Pharmaceuticals, Gilead Sciences, Genentech, Chiesi USA, AbbVie, Translate Bio, and Viatris.